Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome.

Cogo PE, Facco M, Simonato M, Verlato G, Rondina C, Baritussio A, Toffolo GM, Carnielli VP.

Pediatrics. 2009 Nov;124(5):e950-7. doi: 10.1542/peds.2009-0126. Epub 2009 Oct 12.

PMID:
19822594
2.

Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?

Tsakalidis C, Giougki E, Karagianni P, Dokos C, Rallis D, Nikolaidis N.

Turk J Pediatr. 2012 Jul-Aug;54(4):368-75.

PMID:
23692717
3.

Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.

Carnielli VP, Zimmermann LJ, Hamvas A, Cogo PE.

J Perinatol. 2009 May;29 Suppl 2:S29-37. doi: 10.1038/jp.2009.32. Review.

PMID:
19399007
4.

Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.

Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S.

J Perinatol. 2010 Oct;30(10):665-70. doi: 10.1038/jp.2010.20. Epub 2010 Mar 25. Erratum in: J Perinatol. 2012 May;32(5):395.

PMID:
20336076
5.

Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.

Fujii A, Allen R, Doros G, O'Brien S.

J Perinatol. 2010 Oct;30(10):671-6. doi: 10.1038/jp.2010.21. Epub 2010 Mar 25.

PMID:
20336077
6.

Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.

Cai J, Su Z, Zhou Y, Shi Z, Xu Z, Liu J, Xu Z, Yang Y.

Eur J Cardiothorac Surg. 2011 Sep;40(3):557-62. doi: 10.1016/j.ejcts.2011.01.008. Epub 2011 Mar 2.

PMID:
21371901
7.

[Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].

de Winter JP, Egberts J, de Kleine MJ, van Bel F, Wijnands JB, Guit GL.

Ned Tijdschr Geneeskd. 1992 Oct 10;136(41):2018-24. Dutch.

PMID:
1407193
8.

Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes.

Torresin M, Zimmermann LJ, Cogo PE, Cavicchioli P, Badon T, Giordano G, Zacchello F, Sauer PJ, Carnielli VP.

Am J Respir Crit Care Med. 2000 May;161(5):1584-9.

PMID:
10806159
9.

[Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome].

Herting E, Tubman R, Halliday HL, Harms K, Speer CP, Curstedt T, Robertson B.

Monatsschr Kinderheilkd. 1993 Sep;141(9):721-7. German.

PMID:
8413348
10.

A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.

Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R; Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group.

Pediatrics. 2005 Apr;115(4):1030-8.

PMID:
15805381
11.

Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.

Proquitté H, Dushe T, Hammer H, Rüdiger M, Schmalisch G, Wauer RR.

Respir Med. 2007 Jan;101(1):169-76. Epub 2006 May 15.

12.
13.

[Treatment of severe respiratory distress syndrome with surfactant].

Jacobsen T, Verder H, Skov L, Greisen GO, Friis-Hansen B.

Ugeskr Laeger. 1992 Jun 1;154(23):1642-5. Danish.

PMID:
1631999
14.

A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.

Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K; North American Study Group.

Am J Perinatol. 2004 Apr;21(3):109-19.

PMID:
15085492
15.
16.

Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.

Parmigiani S, Panza C, Bevilacqua G.

Acta Biomed Ateneo Parmense. 1997;68 Suppl 1:65-73.

PMID:
10021719
17.

Metabolic precursors of surfactant disaturated-phosphatidylcholine in preterms with respiratory distress.

Cogo PE, Ori C, Simonato M, Verlato G, Isak I, Hamvas A, Carnielli VP.

J Lipid Res. 2009 Nov;50(11):2324-31. doi: 10.1194/jlr.M800514-JLR200. Epub 2009 May 27.

18.

Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome.

Baraldi E, Pettenazzo A, Filippone M, Magagnin GP, Saia OS, Zacchello F.

Pediatr Pulmonol. 1993 Mar;15(3):157-62.

PMID:
8327278
19.
20.

Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.

Choukroun ML, Llanas B, Apere H, Fayon M, Galperine RI, Guenard H, Demarquez JL.

Pediatr Pulmonol. 1994 Nov;18(5):273-8.

PMID:
7898964
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk